Clinical Trial Update: Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA

View source ↗

Summary

A new clinical trial is recruiting to characterize perceived physical fatigability in individuals with spinal muscular atrophy treated with nusinersen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

Sponsor: Columbia University | Conditions: Spinal Muscular Atrophy | Status: RECRUITING